Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Revaccination with DTP3 in African Infants
NCT07005726Phase 4Enrolling by invitation
- Sponsor
- Bandim Health Project
- Start
- May 2025
- Primary completion
- May 2030
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine in Infant mortality (IMR), Infection, sponsored by Bandim Health Project. Started May 2025; status: enrolling by invitation.
02
Drugs
bcg vaccine
03
Conditions
Infant mortality (IMR)Infection
Beyond the preview
Go deeper on NCT07005726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07005726.